Breast Cancer, Male Clinical Trial
Official title:
An Observational, Retrospective Study on the Progress of Breast Cancer Cases in Males and the Assessment of Relapse Risk Through Gene Sequencing
An observational, Other Designs (OD) post-marketing, multicenter study, which will obtain retrospective data from male patients diagnosed with invasive breast cancer between 2000 and 2019 in the medical oncology departments of hospitals that are associated with Spanish Breast Cancer Research Group (GEICAM) (using information obtained from patient medical histories).
One of the objectives of this project is to ensure representativeness of the cases referred to. Accordingly, participating sites agree to enroll in the study male patients who were diagnosed with breast cancer in the period between 2000 and 2019. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT03387553 -
HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer
|
Early Phase 1 | |
| Completed |
NCT03112590 -
Phase I-II Study of Interferon-gamma in Patients With HER-2 Positive Breast Cancer
|
Phase 1/Phase 2 | |
| Terminated |
NCT03630809 -
Immune Response and Potential Booster for Patients Who Have Received HER2-pulsed DC1
|
Phase 2 | |
| Active, not recruiting |
NCT03384914 -
Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer
|
Phase 2 | |
| Withdrawn |
NCT03295695 -
PET-CT Imaging Using FDG-labeled Human Erythrocytes in Breast Cancer Patient
|
Early Phase 1 |